Potential of Imiquimod and Fulvestrant against Mycobacterium tuberculosis using Molecular docking approach
<p>Mycobacterium Tuberculosis cause severe disease of lungs known as Tuberculosis. It is a major cause of morbidity and mortality even in the emerging countries also. However, to prepare an antibiotics drug against Mycobacterium tuberculosis is a major challenge. Two compounds Imiquimod, Fulve...
Gardado en:
Main Authors: | Asma Noor (Author), Muhammad Imran Qadir (Author), Ardas Masood (Author), Jawaria Khan (Author), Sania Ahmad (Author) |
---|---|
Formato: | Libro |
Publicado: |
Open Journal of Chemistry - Peertechz Publications,
2017-07-28.
|
Subjects: | |
Acceso en liña: | Connect to this object online. |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares
-
Molecular Docking studies on possible Neuraminidase Inhibitors of Influenza Virus
por: Jawaria Khan, et al.
Publicado: (2017) -
In-silico analysis of tenidap and its derivative as a novel 5-lipoxygenase inhibitor
por: Asma Noor, et al.
Publicado: (2017) -
Phage therapy: progress in pharmacokinetics
por: Muhammad Imran Qadir, et al.
Publicado: (2018) -
Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy
por: Colombo GL, et al.
Publicado: (2023) -
Molecular docking and network pharmacology-based approaches to explore the potential of terpenoids for Mycobacterium tuberculosis
por: K. Kalaimathi, et al.
Publicado: (2021)